Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Neuroma × Clear all

Phase

Status

Completed 18 Unknown 6 Recruiting 5 Terminated 2 Active not recruiting 2 Withdrawn 1 Suspended 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 386 Neoplasms 270 Carcinoma, Non-Small-Cell Lung 214 Prostatic Neoplasms 207 Colorectal Neoplasms 142 Lung Neoplasms 138 Pancreatic Neoplasms 124 Leukemia, Myeloid, Acute 123 Neoplasm Metastasis 121 Carcinoma, Hepatocellular 111 Multiple Myeloma 107 Lymphoma 103 Head and Neck Neoplasms 93 Melanoma 92 Ovarian Neoplasms 90 Brain Neoplasms 86 Recurrence 82 Leukemia, Lymphocytic, Chronic, B-Cell 79 Leukemia 79 Glioblastoma 75 Colonic Neoplasms 72 Precursor Cell Lymphoblastic Leukemia-Lymphoma 70 Squamous Cell Carcinoma of Head and Neck 68 Lymphoma, Non-Hodgkin 67 Carcinoma, Renal Cell 62 Lymphoma, Follicular 59 Hematologic Neoplasms 59 Lymphoma, Large B-Cell, Diffuse 57 Rectal Neoplasms 54 Stomach Neoplasms 50

Interventions

Indocyanine Green 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06164392 2025-01-01

Evaluation of Neuroma Perfusion with Indocyanine Green Fluorescence Angiography

Northwestern University

Phase 4 Withdrawn

Neuroma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡